YAP1 and Familial prostate cancer: The transcriptional co-activator YAP1 and its paralog TAZ have been found to be overexpressed in prostate cancer, establishing a pro-tumorigenic phenotype which is attenuated upon YAP/TAZ knockdown [46,47].